Company profile for Ascendis Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained-release technologies, to develop a pipeline of best‐in‐class therapeutics that address significant unmet medical needs. The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained releas...
Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained-release technologies, to develop a pipeline of best‐in‐class therapeutics that address significant unmet medical needs. The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Tuborg Boulevard 12 2900 Hellerup Denmark
Telephone
Telephone
+45 70 22 22 44
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/01/05/3212768/0/en/Ascendis-Pharma-to-Participate-in-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

GLOBENEWSWIRE
05 Jan 2026

https://investors.ascendispharma.com/news-releases/news-release-details/ascendis-announces-extension-fda-review-period-transcon-cnp

PRESS RELEASE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/11/25/3194804/0/en/Ascendis-Announces-Extension-of-FDA-Review-Period-for-TransCon-CNP-navepegritide-for-Children-with-Achondroplasia.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/17/3189570/0/en/Results-of-Pivotal-ApproaCH-Trial-of-TransCon-CNP-Navepegritide-in-Children-with-Achondroplasia-Published-in-JAMA-Pediatrics.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186726/0/en/Ascendis-Pharma-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/07/3183644/0/en/New-Pooled-3-Year-Analysis-Confirms-Sustained-Clinically-Meaningful-Improvements-in-Renal-Function-for-TransCon-PTH-Palopegteriparatide-Treated-Adults-with-Hypoparathyroidism.html

GLOBENEWSWIRE
07 Nov 2025

FDA Orange Book

read-more
read-more

Europe

read-more
read-more

01

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 11mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000093

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 13.3mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000109

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength :

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000024

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 3.6mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000031

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 4.3mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000048

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 5.2mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000055

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 6.3mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000062

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 7.6mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000079

Regulatory Info : Approved

Registration Country : Sweden

blank

09

Brand Name : Skytrofa

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Skytrofa

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Solution For Injection

Dosage Strength : 9.1mg

Packaging :

Brand Name : Skytrofa

Approval Date : 11/01/2022

Application Number : 20200909000086

Regulatory Info : Approved

Registration Country : Sweden

blank

10

Brand Name : Yorvipath

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Yorvipath

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : Injectable Solution In Pre-Fil...

Dosage Strength : 168MCG

Packaging :

Brand Name : Yorvipath

Approval Date : 2024-06-19

Application Number : 1231766001

Regulatory Info : Authorized

Registration Country : Spain

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

read-more
read-more

01

Brand Name : Diabulyn 30/70

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Diabulyn 30/70

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : INJ

Dosage Strength : 100I.U.

Packaging : 3X5I.U.

Brand Name : Diabulyn 30/70

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

02

Brand Name : Ascibrex 100

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Ascibrex 100

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : CAP

Dosage Strength : 100mg

Packaging : 60X1mg

Brand Name : Ascibrex 100

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

03

Brand Name : Ascibrex 200

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Ascibrex 200

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : CAP

Dosage Strength : 200mg

Packaging : 30X1mg

Brand Name : Ascibrex 200

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

04

Brand Name : ASCENDOSPOR VAGINAL

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : ASCENDOSPOR VAGINAL

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : VCR

Dosage Strength : 10mg

Packaging : 50X1mg

Brand Name : ASCENDOSPOR VAGINAL

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

05

Brand Name : Zylena 5

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Zylena 5

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : FCT

Dosage Strength : 5mg

Packaging : 30X1mg

Brand Name : Zylena 5

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

06

Brand Name : Zylena 10

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Zylena 10

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : FCT

Dosage Strength : 5mg

Packaging : 30X1mg

Brand Name : Zylena 10

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

07

Brand Name : Pericob 40

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : Pericob 40

arrow
BIO Partnering at JPM
Not Confirmed

Ascendis Pharma

Dosage Form : INJ

Dosage Strength : 40mg/2ml

Packaging : 2X10mg/2ml

Brand Name : Pericob 40

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty